Johnson & johnson false advertising suit update
Johnson & Johnson False Advertising Whistleblower Suit Revived
July 27, 2017
A judicial panel has revived some of the false advertising claims alleged against Johnson & Johnson in a case involving allegedly defective hip replacement devices. The claims, made by two whistleblower physicians, were filed under the False Claims Act against J&J subsidiary DePuy Orthopaedics.
The court dismissed the claims that alleged that DePuy had falsified statements to the U.S. Food and Drug Administration (FDA), but revived claims that DePuy encouraged physicians to request government reimbursement for devices that did not attain FDA design standards.
At issue is whether the devices were promoted as having been approved by the FDA, even if that was not in fact true.
Several of the devices in DePuy’s “Pinnacle” line of hip replacements have been linked with health problems that are associated with metal poisoning. These metal-on-metal hip replacement devices are alleged to be faultily designed so as to permit the release of fragments of potentially toxic metals into the bloodstream.
Metal-on-metal hip devices from various manufacturers have been linked with serious health problems, all of which stem from the fact that their moving parts create friction that may release microscopic metal fragments into the body.
If you’ve had hip replacement surgery, and are suffering from post-operative complications, you may be entitled to significant financial compensation. Contact TheLawFirm.com today for a free consultation.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!